Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 5 results found. Search for [ sbi Research on phase 1 vaccination ]

Results 1 to 5 of 5
BusinessToday.In
April 2, 2021
Sectoral data for February 2021, which accounts for about 90 per cent of the total bank credit deployed by 30 scheduled commercial banks, indicates the credit has jumped in both YTD and YoY basis in agri and services, while there is a deceleration in industry and personal loans


BusinessToday.In
February 1, 2021
Sensex, Nifty Highlights on Budget day, February 1: Almost all the sectors closed in green territory today, rising in the range of 3-6%, except for pharma index


BusinessToday.In
New Delhi, January 8, 2021
Bharat Biotech has sent a proposal to the Drugs Controller General of India (DCGI) to seek its approval for trials of a nasal vaccine against COVID-19. The firm recently introduced Covaxin vaccine in India, which has been approved for emergency use in the country. The trials for nasal vaccine will be conducted on at least 30-45 volunteers above the age of 18 years at four trial sites in the country, including Bhubaneswar, Pune, Nagpur and Hyderabad. Watch the video for more.Also Read: Phase 1 vaccination to cost govt Rs 21,000-27,000 crore: SBI Research


BusinessToday.In
January 8, 2021
The order also stated: 'Those who are found negative shall be kept in compulsory institutional quarantine for a period of 7 days followed by 7 days of home quarantine'


BusinessToday.In
January 8, 2021
Govt aims to vaccinate 30 crore priority individuals by August 2021 and 50 crore private individuals by 2022-end. SBI think tank says India will require around Rs 56,000-72,000 crore to administer vaccines to 80 crore people


PAGES 1 OF 1